Results 171 to 180 of about 54,960 (249)

Personalized prediction model for scar response after radionuclide therapy: development and validation in a Chinese cohort. [PDF]

Front Med (Lausanne)
Su J, Chen J, Wang T, Song T, Xu H, Lin S, Lin T.   +6 more
europepmc   +1 more source

Preclinical Lutetium-177 Intracellular Dosimetry of Target Cancers in Radionuclide Therapy. [PDF]

J Med Phys
Lunev AS, Petrosova KA, Ternovskaya KE, Zakharkina AE, Nigmatulina AI.   +4 more
europepmc   +1 more source

Chelator Optimization and Therapeutic Potential of ¹⁸⁸Re-FAPI for FAP-Targeted Radionuclide Therapy. [PDF]

ACS Med Chem Lett
Liang SH.
europepmc   +1 more source

Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [¹⁷⁷Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer. [PDF]

Pharmaceutics
Zavvar TS, Santo G, Gruber L, Kronthaler A, Hagenbuchner J, Skvortsova I, Piro I, Steiger K, Martinovic V, Minasch D, Löffler-Ragg J, di Santo G, Virgolini IJ, von Guggenberg E.   +13 more
europepmc   +1 more source

Efficacy and Safety of Epidermal Radionuclide Therapy with ¹⁸⁸Re Resin in Patients with Nonmelanoma Skin Cancers: Long-Term Data from a Single Center. [PDF]

J Nucl Med
Castellucci P, Baraldi C, Vetrone L, Zagni F, Malizia C, Morganti AG, Strigari L, Dika E, Fanti S.   +8 more
europepmc   +1 more source

Effects of Targeted Radionuclide Therapy on Cancer Cells Beyond the Ablative Radiation Dose. [PDF]

Int J Mol Sci
Ferro-Flores G, Azorín-Vega E, Ocampo-García B, Luna-Gutiérrez M, Cruz-Nova P, Meléndez-Alafort L.   +5 more
europepmc   +1 more source

Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial. [PDF]

Front Endocrinol (Lausanne)
Kolodziej M, Opalinska M, Mikolajczak R, Hubalewska-Dydejczyk A, Dedecjus M, Kowalska A, Saracyn M, Garnuszek P, Cieszykowska I, Januszkiewicz-Caulier J, Dlugosinska J, Durma AD, Jozwik-Plebanek K, Mroz A, Janiak K, Gasior-Perczak D, Trofimiuk-Muldner M, Sowa-Staszczak A, Braziewicz J, Lenda-Tracz W, Kacperski K, Budzynska A, Kubik A, Pastusiak P, Chalewska W, Borkowska A, Cegla P, Walecka-Mazur A, Szczodry A, Kaminski G.   +29 more
europepmc   +1 more source

Peptide receptor radionuclide therapy in G3 gastroenteropancreatic neuroendocrine tumors: a missed opportunity for European patients? [PDF]

Lancet Reg Health Eur
Panzuto F, Cives M, Strosberg J.
europepmc   +1 more source

Advances in PSMA-Targeted Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer. [PDF]

Cancer Manag Res
Wang J, Yuan H, Xu J, Yang C.
europepmc   +1 more source

Locoregional radionuclide therapy of glioblastoma with [²¹¹At]At-PDA-FAPI. [PDF]

Sci Rep
Ma H, Ye T, Qu G, Qin Y, Liao J, Yang Y, Zhang W, Liu N, Li F.   +8 more
europepmc   +1 more source